Finch Therapeutics reported positive topline results from PRISM3, a Phase II trial of CP101, an oral microbiome drug for the prevention of recurrent C. difficile infection.
Biotech and pharmaceutical companies and health care institutions are on the front lines of not only fighting COVID-19, but working to develop vaccines and therapies against the respiratory illness – often in unexpected ways.
iSpecimen will supply the U.S. Centers for Disease Control and Prevention (CDC) with serum samples from subjects who have previously tested positive for SARS-CoV-2, the virus that causes COVID-19.
With 270 million Americans currently under a “stay at home” directive, only activities deemed “essential” are happening in person. In healthcare, which relies significantly on personal connections – between patients and HCPs, HCPs and pharma reps, and even marketers and their teams – there have been dramatic shifts in the way we all work and operate over the last couple of weeks.
The H3N2 flu originated in Hong Kong in July 1968, appeared in the United States during that September, and is still circulating as a type of Influenza A. Globally, about one million people died until the outbreak faded during the winter of 1969-70.
While fears of a potential coronavirus or flu pandemic continue to grow across the globe, the White House is calling for a 16% cut to the budget of the U.S. Centers for Disease Control (CDC), as well as a 10% cut to the Department of Health and Human Services.
San Diego-based Sorrento Therapeutics rejected a non-binding acquisition proposal from a private equity firm, saying that the offer “significantly undervalues Sorrento and is not in the best interest of the company’s stockholders.”
The rate of first-time opioid prescriptions declined 54 percent between 2012 and 2017 in the U.S., largely because many doctors stopped prescribing the painkillers, according to a study of more than 86 million people covered by private insurance.
An estimated 69,000 to 84,000 Americans were hospitalized due to the flu in the last three months, the Centers for Disease Control and Prevention (CDC) said.
Thirty more people were reported sick after eating Kellogg Co.’s Honey Smacks cereal contaminated with Salmonella, the Centers for Disease Control and Prevention (CDC) said, bringing the total to 130 cases in 36 states.